Arcturus Therapeutics Holdings Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -21.81M-25.51M-71.52M-203.67M9.35M-29.73M-80.94M
Share-based Compensation 1.26M1.98M6.76M28.91M30.61M34.65M37.99M
Gains from Equity Investments 0.30M0.03M0.26M
Gains from Investment Securities 1.18M1.65M3.32M4.65M6.62M7.97M8.08M
Non-cash Items 0.58M0.72M47.11M10.72M3.70M4.98M
Cash from Operations -20.76M-6.45M-42.86M-135.04M31.99M-18.10M-59.75M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.58M0.70M0.90M1.20M1.53M3.00M3.54M
Change in Working Capital
Change in Receivables 4.00M-2.30M-0.05M1.24M-0.60M29.30M-28.09M
Change in Account Payables 0.58M3.15M4.81M-0.77M-3.11M-2.24M1.92M
Change in Accured Expenses 1.69M1.68M11.32M4.13M9.44M-0.59M5.93M
Other Working Capital Changes -0.42M8.97M7.04M32.79M-14.69M38.61M-55.21M
Investing Activities
Capital Expenditures 1.48M0.82M1.74M3.41M7.73M2.90M0.65M
Change in Acquisitions & Divestments 30.21M
Cash from Investing Activities 22.13M-0.82M-1.74M-3.41M-7.73M-2.90M-0.65M
Financing Activities
Cash from Financing Activities 10.20M41.91M436.14M48.02M-2.86M-24.09M5.42M
Additional items
Change in Cash 11.58M34.64M391.54M-90.43M21.41M-45.09M-54.98M
Free Cash Flow -22.24M-7.26M-44.60M-138.45M24.27M-21.00M-60.40M
Net Cash Flow 11.58M34.64M391.54M-90.43M21.41M-45.09M-54.98M